Could a diabetes drug help teens with fatty liver?
Disease control
Not yet recruiting
This study tests whether empagliflozin, a drug used for diabetes, can help teens with non-alcoholic fatty liver disease (NAFLD) and obesity. Forty participants will take either the drug or a placebo for several weeks. The main goal is to see if the drug reduces liver fat measured…
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC